These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17969413)

  • 1. [Use of flow cytometry in diagnosis of urinary bladder cancer].
    Bozhenko VK; Kaprin AD; Kostin AA; Kulinich TM; Kudinova EA; Chazova NL; Mel'nikova NV; Nesterov PV
    Vopr Onkol; 2007; 53(4):468-72. PubMed ID: 17969413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ductal cytofluorometry of urine sediment level in the diagnosis of bladder cancer].
    Kaprin AD; Bozhenko VK; Kulinich TM; Nesterov PV; Kostin AA
    Vopr Onkol; 2006; 52(5):579-81. PubMed ID: 17168371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ductal cytometry of urinary sediment in the diagnosis of bladder cancer].
    Bozhenko BK; Kaprin AD; Kulinich TM; Nesterov PV
    Vopr Onkol; 2009; 55(3):278-84. PubMed ID: 19670726
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early diagnosis of bladder carcinoma].
    Mantur M; Jakubowska I; Kemona H
    Pol Merkur Lekarski; 2005 Feb; 18(104):173-5. PubMed ID: 17877124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage of urinary bladder cancer at first presentation.
    Al-Bazzaz PH
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):628-31. PubMed ID: 19587505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometry in urinary tract malignancies. III. Quantitative analysis of DNA histogram and application to bladder cancer detection, evaluation of the treatment and follow-up examination].
    Matsuura T; Tsujihashi H; Kanda H; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):89-95. PubMed ID: 4010114
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of urinary cytology and future role of flow cytometry.
    Dean PJ; Murphy WM
    Urology; 1985 Oct; 26(4 Suppl):11-5. PubMed ID: 4049625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optical coherence tomography in diagnosis of urinary bladder cancer].
    Danil'chenko DI; Al'-Shukri AS; Tkachuk VN
    Urologiia; 2009; (2):42-4. PubMed ID: 19526873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?].
    Tillou X; Grardel E; Fourmarier M; Bernasconi T; Demailly M; Hakami F; Saint F; Petit J
    Prog Urol; 2008 Jul; 18(7):440-4. PubMed ID: 18602604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.
    Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F
    Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bladder cancer: diagnosis and prognosis--molecularbiological approach for prognostic factors. Discussion].
    Nihon Hinyokika Gakkai Zasshi; 1995 Jan; 86(1):55-65. PubMed ID: 7897922
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
    Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
    BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder lymphoma.
    Johnson MH; Nepple KG; Humphrey PA
    J Urol; 2012 Jul; 188(1):269-70. PubMed ID: 22608747
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential of urinary biomarkers in early bladder cancer diagnosis.
    Lam T; Nabi G
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary calreticulin in the diagnosis of bladder urothelial carcinoma.
    Kageyama S; Isono T; Matsuda S; Ushio Y; Satomura S; Terai A; Arai Y; Kawakita M; Okada Y; Yoshiki T
    Int J Urol; 2009 May; 16(5):481-6. PubMed ID: 19389084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural metastasis in a patient with bladder cancer.
    Bonnin N; El Karak F; Droz JP; Flechon A
    J Clin Oncol; 2008 Jan; 26(2):329-30. PubMed ID: 18182674
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on the diagnosis of urothelial cancer using multi-colour fluorescence in situ hybridization (FISH)--comparative analysis between FISH and cytology].
    Onishi T; Ichikawa T; Igarashi T
    Hinyokika Kiyo; 2008 Apr; 54(4):253-6. PubMed ID: 18516915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.